Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2017 2
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E, Bien E, Stefanowicz J, Szurowska E, Szutowicz-Zielinska E, Koczkowska M, Sigorski D, Kloc W, Rogowski W, Adamkiewicz-Drozynska E. Izycka-Swieszewska E, et al. Among authors: szutowicz zielinska e. Biomed Res Int. 2018 Apr 1;2018:4596812. doi: 10.1155/2018/4596812. eCollection 2018. Biomed Res Int. 2018. PMID: 29805974 Free PMC article.
DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.
Woditschka S, Evans L, Duchnowska R, Reed LT, Palmieri D, Qian Y, Badve S, Sledge G Jr, Gril B, Aladjem MI, Fu H, Flores NM, Gökmen-Polar Y, Biernat W, Szutowicz-Zielińska E, Mandat T, Trojanowski T, Och W, Czartoryska-Arlukowicz B, Jassem J, Mitchell JB, Steeg PS. Woditschka S, et al. Among authors: szutowicz zielinska e. J Natl Cancer Inst. 2014 Jun 19;106(7):dju145. doi: 10.1093/jnci/dju145. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24948741 Free PMC article.
Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.
Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Szutowicz-Zielińska E, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M. Pellanda AF, et al. Among authors: szutowicz zielinska e. Chin J Cancer Res. 2017 Dec;29(6):521-532. doi: 10.21147/j.issn.1000-9604.2017.06.06. Chin J Cancer Res. 2017. PMID: 29353974 Free PMC article.
An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number.
Szutowicz-Zielińska E, Konopa K, Kowalczyk A, Suszko-Każarnowicz M, Duchnowska R, Szczęsna A, Ratajska M, Sowa A, Limon J, Biernat W, Burzykowski T, Jassem J, Dziadziuszko R. Szutowicz-Zielińska E, et al. Oncotarget. 2017 Mar 7;8(10):17270-17278. doi: 10.18632/oncotarget.13793. Oncotarget. 2017. PMID: 27924059 Free PMC article. Clinical Trial.
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M, Thatcher N, Smit EF, Lorigan P, Szutowicz-Zielinska E, Liepa AM, Winfree KB, Peterson P, Guba SC, Socinski MA. Reck M, et al. Among authors: szutowicz zielinska e. Lung Cancer. 2012 Dec;78(3):276-81. doi: 10.1016/j.lungcan.2012.09.002. Epub 2012 Oct 6. Lung Cancer. 2012. PMID: 23043970